Amazing Speakers and Sessions for 2017
| To view this email as a web page, go here. |
|
| R&D 100 Conference Speaker Highlight |
| | Layton H. Smith, PhD , is Director of Drug Discovery and Pharmacology at the Sanford Burnham Prebys Medical Discovery Institute in Orlando, Florida. In this role he provides overall operational and scientific leadership to the Conrad Prebys Center for Chemical Genomics at the Institute, a 30-person drug discovery enterprise equipped with state-of-the-art ultra-high throughput screening and lead discovery capabilities. |
|
|
|
The Burnham Prebys Medical Discovery Institute is part of Lake Nona Medical City - a “650-acre health and life sciences... and a premier location for medical care, research and education,” according to the city of Orlando’s website.
R&D is pleased to welcome Dr. Smith to the 2017 R&D 100 Conference. He will be sharing his experience during a general session on Friday, November 17th.
Reimagining the Drug Discovery Process: Disruptive Innovation in Microcosm will explore the ways in which innovative technologies, new business frameworks and consumerism are poised to overcome traditional barriers in early drug discovery and deliver the medicines of tomorrow.
Don’t miss this exploration of R&D leadership in the life sciences;
join us at the R&D 100 Conference on November 16-17, 2017 in Orlando, FL!
|
|
| | | Don't forget to book your room at our special group rate! Click here to book now. |
| SUBSCRIBE | ABOUT US | ADVERTISE | | We respect your right to privacy - view our policy here. | | This mailbox is unattended, so please do not reply to this message. Contact us for assistance. | | If you no longer wish to receive these emails - unsubscribe here. | This email was sent by: R&D
100 Enterprise Drive - Suite 600 - Rockaway, NJ 07866-2129 | | © 2017 R&D. All rights reserved. |
|
|
|
|
|
|
|
|
